Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Surgical Devices

See what CB Insights has to offer

Founded Year



Asset Sale | AssetsPurchased

Total Raised


About Argomed

Company developing a proprietary, water-induced thermotherapy device and technique to address the non-surgical treatment of benign prostatic hyperplasia (BPH). BPH is a condition that afflicts the majority of men over 60, causing adverse changes in urinary voiding patterns. ArgoMed's initial product received FDA market approval in 1999. Assets acquired by Circon in 2002.

Argomed Headquarter Location

14001 Weston Parkway Suite 103

Cary, North Carolina, 27513,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.